Login / Signup

Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients.

Javier LoriceraSantos CastañedaClara MorianoFrancisco Javier NarváezVicente AldasoroOlga MaizRafael MeleroIgnacio VillaPaloma VelaSusana Romero-YusteJosé L CallejasEugenio de MiguelEva Galíndez-AgirregoikoaFrancisca SiveraJesús C Fernández-LópezCarles GalisteoIván Ferraz-AmaroJulio Sánchez-MartínLara Sánchez-BilbaoMónica Calderón-GoerckeAlfonso CasadoJosé L HernándezMiguel Angel González-GayRicardo Blanco-Alonso
Published in: Therapeutic advances in musculoskeletal disease (2022)
TCZ may have a protective effect against the development of visual complications or new episodes of TVL in GCA. However, once PVL was established, only a few patients improved.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • rheumatoid arthritis
  • risk factors